发明申请
US20120053337A1 SYNTHESIS OF 2'-Deoxy-2'-[18F]FLUORO-5-METHYL-1-B-D-ARABINOFURANOSYLURACIL (18F-FMAU)
有权
合成2'-脱氧-2' - [18 F]氟-5-甲基-1-B-D-阿拉伯呋喃糖基-L-木聚糖(18F-FMAU)
- 专利标题: SYNTHESIS OF 2'-Deoxy-2'-[18F]FLUORO-5-METHYL-1-B-D-ARABINOFURANOSYLURACIL (18F-FMAU)
- 专利标题(中): 合成2'-脱氧-2' - [18 F]氟-5-甲基-1-B-D-阿拉伯呋喃糖基-L-木聚糖(18F-FMAU)
-
申请号: US13183924申请日: 2011-07-15
-
公开(公告)号: US20120053337A1公开(公告)日: 2012-03-01
- 发明人: Zibo Li , Hancheng Cai , Peter S. Conti
- 申请人: Zibo Li , Hancheng Cai , Peter S. Conti
- 申请人地址: US CA Los Angeles
- 专利权人: UNIVERSITY OF SOUTHERN CALIFORNIA
- 当前专利权人: UNIVERSITY OF SOUTHERN CALIFORNIA
- 当前专利权人地址: US CA Los Angeles
- 主分类号: C07H19/09
- IPC分类号: C07H19/09
摘要:
The present invention relates to methods of synthesizing 18F-FMAU. In particular, 18F-FMAU is synthesized using one-pot reaction conditions in the presence of Friedel-Crafts catalysts. The one-pot reaction conditions are incorporated into a fully automated cGMP-compliant radiosynthesis module, which results in a reduction in synthesis time and simplifies reaction conditions. The one-pot reaction conditions are also suitable for the production of 5-substitued thymidine or cytidine analogues. The products from the one-pot reaction (e.g. the labeled thymidine or cytidine analogues) can be used as probes for imaging tumor proliferative activity. More specifically, these [18F]-labeled thymidine or cytidine analogues can be used as a PET tracer for certain medical conditions, including, but not limited to, cancer disease, autoimmunity inflammation, and bone marrow transplant.
公开/授权文献
信息查询
IPC分类: